Skip to main content

Table 6 Value co-creation in C1-INH-HAE

From: Value co-creation in healthcare: evidence from innovative therapeutic alternatives for hereditary angioedema

   Strategy 1 (home-based) Strategy 2 (hospital-based)
Actors Objectives Activities Partecipation to the value creation process Value obtained Activities Partecipation to the value creation process Value obtained
Focal Cost vs quality Offers the therapy at hospital Active (increased)public health due to increased compliance, but less medical costs per attack other than drugs due to treatment at home Offers the therapy at hospital Active Public health
Other market facing Sales Provides the drug and the training for patients and caregivers Active (increased) profits due to increased compliance Provides the drug Active Profits
Public Cost vs quality Funds the focal firm Active (increased) public health due to increased compliance, but less medical costs per attack due to treatment at home.
(increased) social value due to less non-medical costs per attack
Funds the focal firm Active Public health
Personal Quality Involved in self-administration Active Value exceeding quality of care and allowing better life and social conditions Receives the therapy Recipient Care
Private Quality Involved in self-administration Active Value exceeding quality of care of the assisted patient and allowing better life and social conditions Assists the patient Recipient Care of the assisted patient